Afuco™ Anti-Human BTNL9 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-BTNL9 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-BTNL9 antibody increases the inhibition of proliferation of T cells by the soluble multimeric BTNL9 protein, used for treating autoimmune or inflammatory disease.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-074CL |
Pricing | Inquiry |
Host | Human |
Target | BTNL9 |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage | Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |